AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 32 filers reported holding AN2 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,748,389 | $29,050,000 | 0.78% |
| Monashee Investment Management LLC | 233,330 | $1,808,000 | 0.66% |
| BVF INC/IL | 1,616,665 | $12,529,000 | 0.60% |
| Avidity Partners Management LP | 688,330 | $5,335,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 716,538 | $5,553,000 | 0.12% |
| Woodline Partners LP | 107,300 | $832,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $969,000 | 0.01% |
| Citadel Advisors | 1,333,816 | $9,924,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 6,130 | $48,000 | 0.00% |
| CITIGROUP INC | 87,775 | $680,000 | 0.00% |